CASTLE BIOSCIENCES, INC. Operating Income
CASTLE BIOSCIENCES, INC. (CSTL) reported Operating Income of -$3.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-06-30 was -$3.07M.
- CASTLE BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-03-31 was -$18.41M.
- CASTLE BIOSCIENCES, INC. operating income (loss) for the quarter ending 2025-12-31 was -$3.83M, a 194.49% decline year-over-year.
- CASTLE BIOSCIENCES, INC. operating income (loss) for the quarter ending 2025-09-30 was -$6.80M, a 233.96% decline year-over-year.
- CASTLE BIOSCIENCES, INC. operating income (loss) for fiscal 2025 was -$42.81M, a 593.77% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. operating income (loss) for fiscal 2024 was $8.67M.
- CASTLE BIOSCIENCES, INC. operating income (loss) for fiscal 2023 was -$67.98M.
- CASTLE BIOSCIENCES, INC. operating income (loss) for fiscal 2022 was -$72.86M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.07M 10-Q · filed 2026-07-30 | -$21.48M 10-Q · filed 2026-07-30 | -$25.30M derived: sum of 3 quarters · filed 2026-07-30 | -$32.11M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | -$18.41M 10-Q · filed 2026-05-06 | -$22.23M derived: sum of 2 quarters · filed 2026-05-06 | -$29.04M derived: sum of 3 quarters · filed 2026-05-06 | -$33.29M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.63M derived: sum of 2 quarters · filed 2026-02-26 | -$14.88M derived: sum of 3 quarters · filed 2026-07-30 | -$42.81M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$6.80M 10-Q · filed 2025-11-03 | -$11.05M derived: sum of 2 quarters · filed 2026-07-30 | -$38.98M 10-Q · filed 2025-11-03 | -$34.93M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$4.25M 10-Q · filed 2026-07-30 | -$32.18M 10-Q · filed 2026-07-30 | -$28.13M derived: sum of 3 quarters · filed 2026-07-30 | -$23.05M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$27.93M 10-Q · filed 2026-05-06 | -$23.88M derived: sum of 2 quarters · filed 2026-05-06 | -$18.80M derived: sum of 3 quarters · filed 2026-05-06 | -$13.79M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.13M derived: sum of 2 quarters · filed 2026-02-26 | $14.14M derived: sum of 3 quarters · filed 2026-02-26 | $8.67M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $5.08M 10-Q · filed 2025-11-03 | $10.09M derived: sum of 2 quarters · filed 2025-11-03 | $4.62M 10-Q · filed 2025-11-03 | -$1.04M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $5.01M 10-Q · filed 2025-08-04 | -$459.00K 10-Q · filed 2025-08-04 | -$6.12M derived: sum of 3 quarters · filed 2026-02-26 | -$15.76M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$5.47M 10-Q · filed 2025-05-05 | -$11.13M derived: sum of 2 quarters · filed 2026-02-26 | -$20.77M derived: sum of 3 quarters · filed 2026-02-26 | -$41.93M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.30M derived: sum of 2 quarters · filed 2026-02-26 | -$36.45M derived: sum of 3 quarters · filed 2026-02-26 | -$67.98M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$9.64M 10-Q · filed 2024-11-04 | -$30.80M derived: sum of 2 quarters · filed 2024-11-04 | -$62.32M 10-Q · filed 2024-11-04 | -$85.15M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$21.16M 10-Q · filed 2024-08-05 | -$52.68M 10-Q · filed 2024-08-05 | -$75.51M derived: sum of 3 quarters · filed 2025-02-27 | -$97.05M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$31.52M 10-Q · filed 2024-05-02 | -$54.35M derived: sum of 2 quarters · filed 2025-02-27 | -$75.89M derived: sum of 3 quarters · filed 2025-02-27 | -$79.86M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$22.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$44.37M derived: sum of 2 quarters · filed 2025-02-27 | -$48.34M derived: sum of 3 quarters · filed 2025-02-27 | -$72.86M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$21.54M 10-Q · filed 2023-11-02 | -$25.51M derived: sum of 2 quarters · filed 2023-11-02 | -$50.02M 10-Q · filed 2023-11-02 | -$65.19M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | -$3.97M 10-Q · filed 2023-08-02 | -$28.49M 10-Q · filed 2023-08-02 | -$43.66M derived: sum of 3 quarters · filed 2023-08-02 | -$55.47M derived: sum of 4 quarters · filed 2023-08-02 | |||
| 2022-03-31 | -$24.52M 10-Q · filed 2023-05-03 | -$39.69M derived: sum of 2 quarters · filed 2023-05-03 | -$51.50M derived: sum of 3 quarters · filed 2023-05-03 | -$60.31M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | -$15.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$26.98M derived: sum of 2 quarters · filed 2023-02-28 | -$35.80M derived: sum of 3 quarters · filed 2023-02-28 | -$40.08M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | -$11.81M 10-Q · filed 2022-11-02 | -$20.62M derived: sum of 2 quarters · filed 2022-11-02 | -$24.91M 10-Q · filed 2022-11-02 | -$27.94M derived: sum of 4 quarters · filed 2022-11-02 | |||
| 2021-06-30 | -$8.81M 10-Q · filed 2022-08-08 | -$13.09M 10-Q · filed 2022-08-08 | -$16.13M derived: sum of 3 quarters · filed 2022-08-08 | -$20.03M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | -$4.28M 10-Q · filed 2022-05-09 | -$7.32M derived: sum of 2 quarters · filed 2022-05-09 | -$11.22M derived: sum of 3 quarters · filed 2022-05-09 | -$11.86M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$6.93M derived: sum of 2 quarters · filed 2022-02-28 | -$7.58M derived: sum of 3 quarters · filed 2022-02-28 | -$6.54M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | -$3.90M 10-Q · filed 2021-11-08 | -$4.55M derived: sum of 2 quarters · filed 2021-11-08 | -$3.51M 10-Q · filed 2021-11-08 | -$897.00K derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | -$645.00K 10-Q · filed 2021-08-09 | $391.00K 10-Q · filed 2021-08-09 | $3.00M derived: sum of 3 quarters · filed 2021-08-09 | $7.43M derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-10 | $3.65M derived: sum of 2 quarters · filed 2021-05-10 | $8.08M derived: sum of 3 quarters · filed 2021-05-10 | $8.69M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $7.04M derived: sum of 2 quarters · filed 2021-03-11 | $7.65M derived: sum of 3 quarters · filed 2021-03-11 | $7.33M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $4.43M 10-Q · filed 2020-11-09 | $4.43M 10-Q · filed 2019-11-12 | $5.04M derived: sum of 2 quarters · filed 2020-11-09 | $4.71M 10-Q · filed 2020-11-09 | $4.72M 10-Q · filed 2019-11-12 | $9.48M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $608.00K 10-Q · filed 2020-08-10 | $607.62K 10-Q · filed 2019-09-03 | $286.00K 10-Q · filed 2020-08-10 | $286.18K 10-Q · filed 2019-09-03 | $5.05M derived: sum of 3 quarters · filed 2020-08-10 | $2.20M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$322.00K 10-Q · filed 2020-05-11 | $4.45M derived: sum of 2 quarters · filed 2020-05-11 | $1.59M derived: sum of 3 quarters · filed 2020-05-11 | -$1.07M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.92M derived: sum of 2 quarters · filed 2020-03-10 | -$751.10K derived: sum of 3 quarters · filed 2020-03-10 | -$3.84M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | -$2.85M 10-Q · filed 2019-11-12 | -$5.52M derived: sum of 2 quarters · filed 2019-11-12 | -$8.60M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$2.67M 10-Q · filed 2019-09-03 | -$5.75M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |